ArticleFrontiers in endocrinology2022

A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival.

Wu-Hu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.